Thursday 25 February 2021
Home      All news      Contact us      RSS     
channelnewsasia - 3 days ago

GSK and Sanofi start with new COVID-19 vaccine study after setback

GlaxoSmithKline and Sanofi on Monday said they had started a new clinical trial of their protein-based COVID-19 vaccine candidate, reviving their efforts against the pandemic after a setback in December delayed the shot s launch.


Latest News
Hashtags:   

Sanofi

 | 

start

 | 

COVID

 | 

vaccine

 | 

study

 | 

after

 | 

setback

 | 

Sources